New insider activity at AptarGroup ( (ATR) ) has taken place on September 8, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Shiela Vinczeller, the Chief Human Resources Officer of AptarGroup, has recently sold 1,167 shares of the company’s stock, amounting to a total transaction value of $160,999.
Recent Updates on ATR stock
In the last 24 hours, AptarGroup has seen notable developments affecting its stock. The company declared a quarterly cash dividend increase of nearly 7%, reflecting its strong financial performance. KeyBanc initiated coverage with an Overweight rating, citing AptarGroup’s leadership in inhalable drug delivery systems and its transition towards a healthcare-focused business as key growth drivers. This transition is expected to accelerate revenue growth and expand margins. However, Raymond James and Wells Fargo lowered their price targets for AptarGroup, possibly due to temporary challenges despite the company’s strong Q2 2025 results. Analysts are weighing the company’s growth potential against current market conditions and strategic shifts.
Spark’s Take on ATR Stock
According to Spark, TipRanks’ AI Analyst, ATR is a Outperform.
AptarGroup’s strong financial performance and positive earnings call sentiment are key strengths, showing robust profitability and strategic achievements. However, weak technical indicators and valuation concerns weigh down the overall score. The lack of significant corporate events reduces additional influence on the score.
To see Spark’s full report on ATR stock, click here.
More about AptarGroup
YTD Price Performance: -11.00%
Average Trading Volume: 422,194
Technical Sentiment Signal: Sell
Current Market Cap: $9.13B